-
公开(公告)号：US6093733A
公开(公告)日：2000-07-25
申请号：US848359
申请日：1997-04-30
IPC分类号： C07D295/14 , A61K31/13 , A61K31/135 , A61K31/40 , A61K31/42 , A61K31/421 , A61K31/445 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/54 , A61K31/55 , A61P25/00 , A61P25/04 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P25/28 , A61P43/00 , C07C257/16 , C07C257/20 , C07C279/24 , C07D211/14 , C07D211/42 , C07D211/44 , C07D211/46 , C07D211/74 , C07D213/75 , C07D261/02 , C07D263/04 , C07D265/02 , C07D265/06 , C07D267/08 , C07D277/04 , C07D295/185 , C07D295/195 , C07D295/215 , C07D295/28 , C07D211/28 , C07D265/00
CPC分类号： C07D213/75 , C07C257/20 , C07D211/42 , C07D211/44 , C07D211/46 , C07D211/74 , C07D265/02 , C07D277/04 , C07D295/185 , C07D295/195 , C07D295/215 , C07D295/32 , C07C2101/14 , C07C2103/74
摘要： This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of which is mediated by muscarinic receptor agonism.
摘要翻译： 本发明涉及一类新的部分或全部毒蕈碱受体激动剂的制备中间体，以及用于治疗或预防由毒蕈碱受体激动剂介导的治疗或预防的疾病的药物组合物和方法。
-
公开(公告)号：US06911477B2
公开(公告)日：2005-06-28
申请号：US10376138
申请日：2003-02-28
IPC分类号： C07C257/20 , C07D211/42 , C07D211/44 , C07D211/46 , C07D211/74 , C07D213/75 , C07D265/02 , C07D277/04 , C07D295/185 , C07D295/195 , C07D295/215 , C07D295/28 , A61K31/135 , A61K31/155
CPC分类号： C07D295/185 , C07C257/20 , C07C2601/14 , C07C2603/74 , C07D211/42 , C07D211/44 , C07D211/46 , C07D211/74 , C07D213/75 , C07D265/02 , C07D277/04 , C07D295/195 , C07D295/215 , C07D295/32
摘要： This invention relates to a novel class of partial or full muscarinic receptor agonists intermediates for their preparation, and pharmaceutical compositions and methods of use for the treatment or prevention of diseases the treatment or prevention of which is mediated by muscarinic receptor agonism.
摘要翻译： 本发明涉及一类新的部分或全部毒蕈碱受体激动剂的制备中间体，以及用于治疗或预防由毒蕈碱受体激动剂介导的治疗或预防的疾病的药物组合物和方法。
-
搜索结果
2 条记录 (耗时 0.011 秒)
